NasdaqCM - Delayed Quote USD
ESSA Pharma Inc. (EPIX)
1.7000
-0.0100
(-0.58%)
At close: May 19 at 4:00:01 PM EDT
Research Analysis
Earnings Estimate
| Currency in CAD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -0.24 | -0.23 | -1.01 | -0.7 |
| Low Estimate | -0.24 | -0.23 | -1.01 | -0.7 |
| High Estimate | -0.24 | -0.23 | -1.01 | -0.7 |
| Year Ago EPS | -0.22 | -0.2 | -0.91 | -1.01 |
Revenue Estimate
| Currency in CAD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in CAD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.32 | -0.27 | -0.25 | -0.27 |
| EPS Actual | -0.22 | -0.2 | -0.27 | -0.19 |
| Difference | 0.1 | 0.07 | -0.02 | 0.08 |
| Surprise % | 30.06% | 26.67% | -6.69% | 28.19% |
EPS Trend
| Currency in CAD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.24 | -0.23 | -1.01 | -0.7 |
| 7 Days Ago | -0.12 | -0.12 | -1.01 | -0.51 |
| 30 Days Ago | -0.12 | -0.12 | -1.01 | -0.51 |
| 60 Days Ago | -0.12 | -0.12 | -0.68 | -0.45 |
| 90 Days Ago | -0.12 | -0.12 | -0.67 | -0.44 |
EPS Revisions
| Currency in CAD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | 1 |
| Up Last 30 Days | -- | -- | -- | 1 |
| Down Last 7 Days | 1 | 1 | 1 | -- |
| Down Last 30 Days | 1 | 1 | 1 | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| EPIX | -9.61% | -14.91% | -11.31% | 30.97% |
| S&P 500 | 13.32% | 2.67% | 7.78% | 13.75% |
Upgrades & Downgrades
| Downgrade | Piper Sandler: Overweight to Neutral | 11/4/2024 |
| Downgrade | Oppenheimer: Outperform to Perform | 11/4/2024 |
| Downgrade | Jones Trading: Buy to Hold | 11/1/2024 |
| Maintains | Oppenheimer: Outperform to Outperform | 5/16/2024 |
| Reiterates | Oppenheimer: Outperform to Outperform | 12/13/2023 |
| Reiterates | Oppenheimer: Outperform to Outperform | 8/9/2023 |
Related Tickers
HLVX HilleVax, Inc.
1.9500
-1.02%
CRGX CARGO Therapeutics, Inc.
4.0900
-0.73%
IPSC Century Therapeutics, Inc.
0.5543
-1.02%
TBPH Theravance Biopharma, Inc.
9.39
+2.07%
RPTX Repare Therapeutics Inc.
1.3800
+2.99%
BOLT Bolt Biotherapeutics, Inc.
0.3277
+11.84%
PRTC.L PureTech Health plc
128.00
-2.14%
IKNA Ikena Oncology, Inc.
1.1100
0.00%
ASMB Assembly Biosciences, Inc.
13.80
+2.83%
ANTX AN2 Therapeutics, Inc.
1.1900
-1.65%